Inotiv, Inc.
NOTVDelisted Jul 10, 2026- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0000720154
Inotiv, Inc. was delisted on Jul 10, 2026; its insiders filed their last Form 4 on Jul 20, 2026; 51 institutions reported holding it in 13F filings for Q1 2026, worth $1.39M in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 11:27 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $68.6M (13.4% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 17, 2025 | Dec 3, 2024 | Dec 11, 2023 | Dec 12, 2022 | Dec 7, 2021 |
| Revenue | $513.0M | $490.7M | $572.4M | $547.7M | $89.6M |
| Cost of revenue | – | – | – | – | $59.4M |
| Gross profit | – | – | – | – | $30.2M |
| Operating expenses | – | – | – | – | $35.8M |
| Research and development | – | – | – | – | $405.0K |
| Selling, general and administrative | $71.1M | $77.0M | $108.2M | $82.4M | $30.4M |
| Operating income | -$30.9M | -$86.4M | -$81.5M | -$263.5M | -$5.62M |
| Interest expense | – | – | $43.0M | $29.7M | $1.68M |
| Income tax | -$19.1M | -$21.9M | -$19.3M | -$15.2M | -$4.78M |
| Net income | -$68.6M | -$108.4M | -$105.1M | -$337.0M | $10.9M |
| EPS, basic | $-2.11 | $-4.19 | $-4.10 | $-13.84 | $0.83 |
| EPS, diluted | $-2.11 | $-4.19 | $-4.10 | $-13.84 | $0.19 |
| Weighted shares, basic | 32.5M | 25.9M | 25.6M | 24.4M | 13.2M |
| Weighted shares, diluted | 32.5M | 25.9M | 25.6M | 24.4M | 13.9M |
| Margins and growth | |||||
| Gross margin | – | – | – | – | 33.7% |
| Operating margin | -6.0% | -17.6% | -14.2% | -48.1% | -6.3% |
| Net margin | -13.4% | -22.1% | -18.4% | -61.5% | 12.2% |
| Revenue growth, year over year | +4.5% | −14.3% | +4.5% | +511.2% | +48.2% |
| Net income growth, year over year | – | – | – | −3,193.3% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 17, 2025 | Dec 3, 2024 | Dec 11, 2023 | Dec 12, 2022 | Dec 7, 2021 |
| Cash and equivalents | $21.7M | $21.4M | $35.5M | $18.5M | $138.9M |
| Accounts receivable | – | – | – | $88.9M | $20.7M |
| Inventory | $45.7M | $18.2M | $56.1M | $71.4M | $602.0K |
| Total current assets | $194.6M | $163.4M | $213.8M | $233.0M | $189.0M |
| Property, plant and equipment | $180.7M | $188.3M | $191.1M | $186.2M | $48.0M |
| Goodwill | $94.3M | $94.3M | $94.3M | $157.8M | $51.9M |
| Intangible assets | $240.2M | $274.4M | $308.4M | $345.9M | $24.2M |
| Total assets | $771.1M | $781.4M | $856.5M | $962.9M | $321.9M |
| Accounts payable | $48.5M | $33.5M | $32.6M | $28.7M | $6.16M |
| Short-term debt | $402.1M | $3.54M | $7.95M | $7.98M | $9.66M |
| Total current liabilities | $556.8M | $119.0M | $132.2M | $164.1M | $55.1M |
| Long-term debt | $0 | $389.8M | $369.8M | $330.7M | $154.2M |
| Total liabilities | $635.1M | $610.9M | $588.0M | $603.1M | $216.7M |
| Shareholders' equity | $136.0M | $170.5M | $268.5M | $359.8M | $105.1M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 17, 2025 | Dec 3, 2024 | Dec 11, 2023 | Dec 12, 2022 | Dec 7, 2021 |
| Operating cash flow | -$10.5M | -$6.80M | $27.9M | -$5.22M | $10.7M |
| Capital expenditures | $16.6M | $22.3M | $27.5M | $36.3M | $12.5M |
| Free cash flow | -$27.1M | -$29.1M | $380.0K | -$41.5M | -$1.73M |
| Depreciation and amortization | $55.9M | $57.1M | $54.7M | $49.3M | $6.27M |
| Stock-based compensation | $6.03M | $6.74M | $7.84M | $24.2M | $1.79M |
| Investing cash flow | -$12.9M | -$16.8M | -$28.8M | -$333.7M | -$54.1M |
| Financing cash flow | $23.7M | $9.68M | $15.9M | $203.2M | $198.8M |
| Net change in cash | $309.0K | -$14.1M | $16.5M | -$137.9M | $155.5M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.2% | 1.4% | 1.4% | 4.4% | 2.0% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Apr 16, 2026 | 34.9M | +1.6% | SEC |
| Jan 23, 2026 | 34.4M | +1.6% | SEC |
| Jan 20, 2026 | 34.4M | +1.6% | SEC |
| Nov 21, 2025 | 34.4M | +32.1% | SEC |
| Jul 31, 2025 | 34.4M | +32.1% | SEC |
| Apr 30, 2025 | 34.4M | +32.3% | SEC |
| Jan 30, 2025 | 33.9M | +31.3% | SEC |
| Nov 15, 2024 | 26.0M | +0.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.